Tortoise Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $284K | Buy |
1,128
+80
| +8% | +$17.2K | 0.02% | 213 |
|
|
2026
Q1 | $228K | Buy |
1,048
+70
| +7% | +$15.5K | 0.02% | 224 |
|
|
2025
Q4 | $223K | Sell |
978
-40
| -4% | -$9.11K | 0.02% | 220 |
|
|
2025
Q3 | $236K | Buy |
1,018
+26
| +3% | +$5.29K | 0.02% | 215 |
|
|
2025
Q2 | $184K | Buy |
992
+86
| +9% | +$16K | 0.02% | 228 |
|
|
2025
Q1 | $190K | Sell |
906
-400
| -31% | -$77.8K | 0.02% | 218 |
|
|
2024
Q4 | $232K | Sell |
1,306
-32
| -2% | -$5.88K | 0.02% | 205 |
|
|
2024
Q3 | $264K | Buy |
1,338
+233
| +21% | +$43.5K | 0.03% | 198 |
|
|
2024
Q2 | $190K | Buy |
1,105
+99
| +10% | +$16.4K | 0.02% | 214 |
|
|
2024
Q1 | $183K | Sell |
1,006
-25
| -2% | -$4.31K | 0.02% | 227 |
|
|
2023
Q4 | $160K | Sell |
1,031
-120
| -10% | -$17.5K | 0.02% | 235 |
|
|
2023
Q3 | $172K | Sell |
1,151
-9
| -0.8% | -$1.32K | 0.03% | 210 |
|
|
2023
Q2 | $156K | Sell |
1,160
-19
| -2% | -$2.79K | 0.02% | 224 |
|
|
2023
Q1 | $188K | Sell |
1,179
-45
| -4% | -$6.88K | 0.03% | 195 |
|
|
2022
Q4 | $198K | Buy |
1,224
+87
| +8% | +$13.3K | 0.03% | 187 |
|
|
2022
Q3 | $153K | Buy |
1,137
+458
| +67% | +$65.7K | 0.03% | 201 |
|
|
2022
Q2 | $104K | Buy |
679
+65
| +11% | +$9.93K | 0.02% | 221 |
|
|
2022
Q1 | $100K | Buy |
614
+166
| +37% | +$24.1K | 0.02% | 229 |
|
|
2021
Q4 | $61K | Hold |
448
| – | – | 0.01% | 274 |
|
|
2021
Q3 | $48K | Sell |
448
-34
| -7% | -$3.88K | 0.01% | 280 |
|
|
2021
Q2 | $54K | Buy |
482
+130
| +37% | +$14.6K | 0.01% | 267 |
|
|
2021
Q1 | $38K | Buy |
352
+28
| +9% | +$3K | 0.01% | 283 |
|
|
2020
Q4 | $35K | Buy |
324
+69
| +27% | +$6.63K | 0.01% | 270 |
|
|
2020
Q3 | $22K | Sell |
255
-8
| -3% | -$753 | 0.01% | 297 |
|
|
2020
Q2 | $26K | Sell |
263
-192
| -42% | -$16.9K | 0.01% | 273 |
|
|
2020
Q1 | $35K | Hold |
455
| – | – | 0.01% | 253 |
|
|
2019
Q4 | $40K | Sell |
455
-59
| -11% | -$4.9K | 0.01% | 256 |
|
|
2019
Q3 | $39K | Sell |
514
-100
| -16% | -$6.86K | 0.01% | 257 |
|
|
2019
Q2 | $45K | Sell |
614
-289
| -32% | -$22.7K | 0.01% | 262 |
|
|
2019
Q1 | $73K | Buy |
903
+200
| +28% | +$16.4K | 0.02% | 210 |
|
|
2018
Q4 | $65K | Buy |
703
+200
| +40% | +$17.6K | 0.02% | 211 |
|
|
2018
Q3 | $48K | Sell |
503
-168
| -25% | -$15.9K | 0.01% | 242 |
|
|
2018
Q2 | $62K | Hold |
671
| – | – | 0.02% | 223 |
|
|
2018
Q1 | $64K | Sell |
671
-241
| -26% | -$26.5K | 0.02% | 217 |
|
|
2017
Q4 | $88K | Buy |
912
+589
| +182% | +$55.5K | 0.03% | 195 |
|
|
2017
Q3 | $29K | Hold |
323
| – | – | 0.01% | 271 |
|
|
2017
Q2 | $23K | Buy |
323
+223
| +223% | +$15K | 0.01% | 277 |
|
|
2017
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 362 |
|
|
2016
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 379 |
|
|
2016
Q3 | $6K | Buy |
+100
| New | +$6.47K | ﹤0.01% | 356 |
|
|
2016
Q1 | – | Sell |
-986
| Closed | -$58K | – | 391 |
|
|
2015
Q4 | $58K | Buy |
986
+175
| +22% | +$10.1K | 0.02% | 194 |
|
|
2015
Q3 | $44K | Hold |
811
| – | – | 0.02% | 209 |
|
|
2015
Q2 | $54K | Hold |
811
| – | – | 0.02% | 204 |
|
|
2015
Q1 | $47K | Hold |
811
| – | – | 0.02% | 214 |
|
|
2014
Q4 | $53K | Sell |
811
-150
| -16% | -$9.46K | 0.02% | 207 |
|
|
2014
Q3 | $56K | Sell |
961
-439
| -31% | -$24.4K | 0.02% | 198 |
|
|
2014
Q2 | $79K | Hold |
1,400
| – | – | 0.03% | 173 |
|
|
2014
Q1 | $72K | Hold |
1,400
| – | – | 0.03% | 167 |
|
|
2013
Q4 | $74K | Hold |
1,400
| – | – | 0.04% | 157 |
|
|
2013
Q3 | $63K | Sell |
1,400
-26
| -2% | -$1.15K | 0.04% | 138 |
|
|
2013
Q2 | $59K | Buy |
+1,426
| New | +$62.4K | 0.04% | 132 |
|
Other funds holding ABBV
VCM
VPM
Tortoise Investment Management's ABBV Position: Q2 2026 in Review
Tortoise Investment Management increased its AbbVie (ABBV) stake by 7.6% in Q2 2026, buying an estimated $17.2K and bringing the position to 1,128 shares worth $284K. The position accounts for 0.02% of the portfolio, ranked #213.
Tortoise Investment Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. 3,649 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Tortoise Investment Management held 1,128 shares of AbbVie worth $284K as of Q2 2026.
- Tortoise Investment Management bought 80 AbbVie shares in Q2 2026, an estimated $17.2K.
- AbbVie made up 0.02% of Tortoise Investment Management's portfolio in Q2 2026, its #213 holding.
- Tortoise Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- 3,649 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Tortoise Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.